Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model

Toxicology Letters

Volumn 220, Issue 3, 2013, Pages 205-218

  Tahir, Mir ^a   Rehman, Muneeb U ^a   Lateef, Abdul ^a   Khan, Abdul Quaiyoom ^a   Khan, Rehan ^a   Qamar, Wajhul ^a   O'Hamiza, Oday ^a   Ali, Farrah ^a   Hasan, Syed Kazim ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Chemoprevention; Diosmin; Hepatocellular carcinoma; Hyperproliferation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; DIOSMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; LACTATE DEHYDROGENASE; N (2 FLUORENYL)ACETAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

2-ACETYLAMINOFLUORENE; ANIMALS; CELL PROLIFERATION; CYCLOOXYGENASE 2; DIETHYLNITROSAMINE; DIOSMIN; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE DECARBOXYLASE; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; RATTUS; RATTUS NORVEGICUS;

EID: 84879487042     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.04.004     Document Type: Article

References (84)

1. Abrams P., Marsh J.W. Current approach to hepatocellular carcinoma. Surgical Clinics of North America 2010, 90:803-816.
2. Anzola M., Burgos J.J. Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis. Expert Reviews in Molecular Medicine 2003, 5:1-16.
3. Athar M., Sharma S.D., Iqbal M., Sultana S., Pandaya K.B., Tripathi I.P. Coordination of copper polyamines complex with immidiozoles potentiates its superoxide dismutase mimicking activity and abolishes its interactions with albumin. Biochemistry and Molecular Biology International 1996, 39:813-821.
4. Benhar M., Engelberg D., Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Reports 2002, 3:420-425.
5. Benson A.M., Hunkalar M.J., Talalay P. Increase of NADPH, quinone reductase activity by dietary antioxidant: possible role in protection against carcinogenesis and toxicity. Proceedings of the National Academy of Sciences of the United States of America 1980, 77:5116-5220.
6. Best D.H., Coleman W.B. Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. Journal of Hepatology 2007, 46:1055-1063.
7. Cambruzzi E., Zettler C.G., Alexandre C.O. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma. Pathology Oncology Research 2005, 11(2):114-120.
8. Carlberg I., Mannervik B. Glutathione level in rat brain. Journal of Biological Chemistry 1975, 250:4480-4575.
9. Chakraborty T., Chatterjee A., Dhachinamoorthi D., Srivastava S., Panayappan L., Chatterjee M. Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats. Environmental and Molecular Mutagenesis 2006, 47:603-617.
10. Chodon D., Mumtaz Banu S., Padmavathi R., Sakthisekaran D. Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma. Molecular and Cellular Biochemistry 2007, 297:73-80.
11. Chung W.Y., Park J.H., Kim M.J., Kim H.O., Hwang J.K., Lee S.K., Park K.K. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stagemouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis 2007, 28:1224-1231.
12. Claiborne A. Catalase activity. CRC Handbook of Methods in Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton. R.A. Greenwald (Ed.).
13. Clevers H. At the crossroads of inflammation and cancer. Cell 2004, 118:671-674.
14. Cohen S.M., Ellwin L.B. Cell proliferation in carcinogenesis. Science 1990, 249:1007-1011.
15. Crowell J.A. The chemopreventive agent development research program in the division of cancer prevention of the US National Cancer Institute: an overview. European Journal of Cancer 2005, 41:1889-1910.
16. Dorai T., Aggarwal B.B. Role of chemopreventive agents in cancer therapy. Cancer Letters 2004, 215:129-140.
17. Dung T.D., Day C.H., Binh T.V., Lin C.H., Hsu H.H., Su C.C., Lin Y.M., Tsai F.J., Kuo W.W., Chen L.M., Huang C.Y. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression. Food and Chemical Toxicology 2012, 50(5):1802-1810.
18. Eldrige S.R., Butterworth B.E., Goldsworthy T.L. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Environmental Health Perspectives 1993, 101:211-218.
19. F'guyer S., Afaq F., Mukhtar H. Photochemoprevention of skin cancer by botanical agents. Photodermatology, Photoimmunology and Photomedicine 2003, 19:56-72.
20. Farber E. Clonal adaptation during carcinogenesis. Biochemical Pharmacology 1990, 39:1837-1846.
21. Farber E. Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Digestive Diseases and Sciences 1991, 36:973-978.
22. Farber E., Cameron R. The sequential analysis of cancer development. Advances in Cancer Research 1980, 35:125-226.
23. Gupta R.C., Earley K., Becker F.F. Analysis of DNA adducts in putative premalignant hepatic nodules and non-target tissues of rats during 2-acetylaminofluorene carcinogenesis. Cancer Research 1988, 48:5270-5274.
24. Habig W.H., Pabst M.J., Jokoby W.B. GST: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974, 249:7130-7139.
25. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine 1993, 329:1318-1327.
26. Hirahu Y., Yamashita N., Nishiguchi M., Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. International Journal of Cancer 2001, 92:333-337.
27. Hwang E.S., Bowen P.E. DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment. Critical Reviews in Food Science and Nutrition 2007, 47:27-50.
28. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664.
29. Itaya M., Yoshimoto J., Kojima K., Kawasaki S. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity. Methods in Molecular Medicine 2005, 110:213-227.
30. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61(2):69-90.
31. Jollow D.J., Mitchell J.R., Zampaglione N., Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4, bromobenzene oxide as the hepatotoxic intermediate. Pharmocology 1974, 11:151-169.
32. Kaiser G.M., Sotiropoulos G.C., Sgourakis G., Bleck J., Baba H.A., Beckebaumr S., Gerken G., Paul A., Trarbach T. Surgical treatment of Klatskin tumor: liver resection versus transplantation. Hepato-Gastroenterology 2010, 57:1337-1340.
33. Kastan M.B., Onyekwere O., Sidransky D., et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991, 51:6304-6311.
34. Kelley D.J., Mestre J.R., Subbaramaiah K., et al. Benzoapyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 1997, 18:795-799.
35. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997, 14:629-640.
36. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007, 47:89-116.
37. Khan T.H., Sultana S. Effect of Aegle marmelos on DEN initiated and 2-AAF promoted hepatocarcinogenesis: a chemopreventive study. Toxicology Mechanisms and Methods 2011, 21(6):453-462.
38. Kim E.Y., Kim E.K., Lee H.S., Sohn Y., Soh Y., Jung H.S., et al. Protective effects of Cuscutae semen against diethylnitrosamine-induced acute liver injury in Sprague-Dawley rats. Biological and Pharmaceutical Bulletin 2007, 30:1427-1431.
39. Klaunig J.E., Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annual Review of Pharmacology and Toxicology 2004, 44:239-267.
40. Klohn P.C., Massalha H., Neumann H.G. A metabolite of carcinogen 2-acetyl aminofluorene induces redox cycling in mitochondria. Biochimica et Biophysica Acta 1995, 1229:363-372.
41. Kohle C., Schwarz M., Bock K.W. Promotion of hepatocarcinogenesis in humans and animal models. Archives of Toxicology 2008, 82:623-631.
42. Korenberg A. Lactic dehydrogenase of muscle. Methods in Enzymology 1955, vol. I:441-443. Academic Press, New York.
43. Kubicka S., Kühnel F., Zender L., Rudolph K.L., Plümpe J., Manns M., Trautwein C. p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. Journal of Biological Chemistry 1999, 274:32137-32144.
44. Kumar B., Koul S., Khandrika L., Meacham R.B., Koul H.K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Research 2008, 68:1777-1785.
45. Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
46. Lee J.S., Chu I.S., Mikaelyan A., Calvisi D.F., Heo J., Reddy J.K., et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nature Genetics 2004, 36:1306-1311.
47. Lee J.C., Kundu J.K., Hwang D.M., Na H.K., Surh Y.J. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Carcinogenesis 2007, 28:1491-1498.
48. Li X., Zhou X.P., Guan Y.S., Wang Y.X. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary and Pancreatic Diseases International: HBPD INT 2005, 4:427-432.
49. Lowry O.M., Rosenbrough N.J., Farr A., Randall l.R.J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
50. Lu S., Zhan A.H., Huang X.X., Ren Y.J. Expression and significance proliferating cell nuclear antigen in resistance of lithium carbonate to aflatoxins B1 induced hepatocarcinogenesis in rats. Alibian Jibian Tubian 2002, 14:84-86.
51. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Research 1984, 44:5086-5091.
52. Moon N.S., Di Stefano L., Morris E.J., Patel R., White K., Dyson N.J. E2F and p53 induce apoptosis independently during Drosophila development but intersect in the context of DNA damage. PLoS Genetics 2008, 4:e1000153.
53. Nakano A., Watanabe N., Nishizaki Y., Takashimizu S., Matsuzaki S. Immunohisto-chemical studies on the expression of P-glycoprotein and p53 in relation to histological differentiation and cell proliferation in hepatocellular carcinoma. Hepatology Research 2003, 25:158-165.
54. Ng I.O., Lai E.C., Fan S.T., Ng M., Chan A.S., So M.K. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994, 73:2268-2274.
55. Nogata Y., Ohta H., Yoza K., Berhow M., Hasegawa S. High performance liquid chromatographic determination of naturally occurring flavonoids in Citrus with a photodiode-ray detector. Journal of Chromatography 1994, 667:59-66.
56. O'Brien T.G., Simsiman R.C., Boutwell R.K. Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Research 1975, 35:1662-1670.
57. Oyama K., Shiota G., Ito H., Murawaki Y., Kawasaki H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 2002, 23(5):885-892.
58. Pantano C., Reynaert N.L., van der Vliet A., Janssen-Heininger Y.M. Redox-sensitive kinases of the nuclear factor-kappaB signalling pathway. Antioxidants and Redox Signalling 2006, 8:1791-1806.
59. Park D.Y., Suh K.S. Transforming growth factor-beta1 protein, proliferation and apoptosis of oval cells in acetylaminofluorene induced rat liver regeneration. Journal of Korean Medical Science 1999, 14:531-538.
60. Peto R., Gary R., Brantom P., Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Research 1991, 51:6452-6469.
61. 2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimulus. Cellular Immunology 1981, 59:301-308.
62. Rehman M.U., Tahir M., Khan A.Q., Khan R., Lateef A., Hamiza O.O., Ali F., Sultana S. Diosmin protects against trichloroethylene-induced renal injury in Wistar rats: plausible role of p53, Bax and caspases. British Journal of Nutrition 2013, 12:1-12.
63. Reitman S., Frankel S.A. Colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology 1957, 28:56-63.
64. Sahin A.A., Ro J.Y., Brown R.W., Ordonez N.G., Cleary K.R., el-Naggar A.K., Wilson P., Ayala P.G. Assessment of Ki-67 derived tumor proliferative activity in colorectal adenocarcinomas. Modern Pathology 1994, 17:17-22.
65. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. Journal of Cellular Physiology 2000, 182:311-322.
66. Sehrawat A., Sultana S. Evaluation of possible mechanisms of protective role of Tamarix gallica against DEN initiated and 2-AAF promoted hepatocarcinogenesis in male Wistar rats. Life Sciences 2006, 79(15):1456-1465.
67. Sehrawat A., Sultana S. Chemoprevention by Butea monosperma of hepatic carcinogenesis and oxidative damage in male wistar rats. Asian Pacific Journal of Cancer Prevention: APJCP 2006, 7(1):140-148.
68. Silambarasan T., Raja B. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. European Journal of Pharmacology 2012, 679(1-3):81-89.
69. Solt D.B., Farber E. A new principle for the analysis of chemical carcinogenesis. Nature 1976, 263:701-703.
70. Srinivasan S., Pari L. Ameliorative effect of diosmin, a Citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chemico-Biological Interactions 2012, 195(1):43-51.
71. Subbaramaiah K., Telang N., Ramonetti J.T., et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Research 1996, 56:4424-4429.
72. Sultana S., Ahmed S., Jahangir T. Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats. Journal of Ethnopharmacology 2008, 118(1):1-6.
73. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews. Cancer 2003, 3:768-780.
74. Surh Y.J., Na H.K., Lee J.Y., Keum Y.S. Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. Journal of Korean Medical Science 2001, 16:S38-S41.
75. Surh Y.J., Kundu J.K., Na H.K., Lee J.S. Redox-sensitive transcription factors asprime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. Journal of Nutrition 2005, 135:2993-3001.
76. Taha M.M., Abdul A.B., Abdullah R., Ibrahim T.A., Abdelwahab S.I., Mohan S. Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chemico-Biological Interactions 2010, 186(3):295-305.
77. Tiwawech D., Hasegawa R., Kurata Y., Tatematsu M., Shibata M.A., Thamavit W., Wilkinson I.V.J., Clapper M. Detoxification enzymes and chemoprevention. Proceedings of the Society for Experimental Biology and Medicine 1997, 216:192-200.
78. Verna L., Whysner J., Williams G.M. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation. DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacology and Therapeutics 1996, 71:57-81.
79. Vogelstein B., Kinzler K.W. Carcinogens leave fingerprints. Nature 1992, 355:209-210.
80. Wang C., Liu Z. Arabidopsis ribonucleotide reductases are critical for cell cycle progression. DNA damage repair, and plant development. Plant Cell 2006, 18:350-365.
81. Wild C.P., Hall A.J. Primary prevention of hepatocellular carcinoma in developing countries. Mutation Research 2000, 462:381-393.
82. Wright J.R., Colby H.D., Miles P.R. Cytosolic factors that affect microsomal lipid peroxidation in lung and liver. Archives of Biochemistry and Biophysics 1981, 206:296-304.
83. Youssef M.I., Maghraby H., Youssef E.A., El-Sayed M.M. Expression of Ki 67 in hepatocellular carcinoma induced by diethylnitrosamine in mice and its correlation with histopathological alterations. Journal of Applied Pharmaceutical Science 2012, 2(3):52-59.
84. Zhang W., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research 2002, 12(1):9-18.